Mode
Text Size
Log in / Sign up
N/A N=90 Supportive Care

Social Support Intervention for Older Adults With T2DM

Type 2 Diabetes

Enrolled (actual)
90
Serious AEs
Results posted
Feb 2025
Primary outcome: Primary: Hemoglobin A1c — 7.004; 6.24; 6.47 percentage of hemoglobin

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Diabetes Empowerment Education Program (Other)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Brittany L Smalls
Primary completion
Dec 2023

Outcome Measures

OutcomeResultp-value
PRIMARY
Hemoglobin A1c
7.004; 6.24; 6.47
SECONDARY
Systolic Blood Pressure
127.59; 129.57; 129.71
SECONDARY
Diastolic Blood Pressure
73.59; 77.42; 77.28
SECONDARY
Lipids
SECONDARY
Self-care
6.93; 8.08; 8.75
SECONDARY
Medication Adherence
0.84; 0.60; 0.57
SECONDARY
Health-related Quality of Life Measures
9.45; 9.20; 9.14

Summary

This study seeks to describe and evaluate the impact of social support on self-care and clinical outcomes in rural-dwelling older adults with T2DM, test the feasibility and preliminary effectiveness of a 6-week intervention administered by community health workers targeting rural dwelling older adults with T2DM (seed) and an individual within their social support network (alter).

Eligibility Criteria

"Seeds" Inclusion Criteria:

  • confirmed diagnosis of T2DM via electronic medical record
  • age 65 years or older
  • lives within Leslie County
  • able to provide consent
  • have had at least one clinic visit in the past year

"Seeds" Exclusion Criteria:

  • no diagnosis of T2DM via electronic medical record
  • under 65 years of age
  • unable to speak and understand English
  • unable to consent

"Alters" Inclusion Criteria

  • 18 years of age or older
  • able to provide consent
  • has at least weekly contact with the seed

"Alters" Exclusion Criteria

  • under 18 years of age
  • unable to speak and understand English
  • unable to consent
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04568486). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search